Based on recent data, Health Catalyst, Inc. (HCAT) shows an Average True Range (ATR) of 0.14 and an Enterprise Value of 495.93M. Its average trading volume over the past 3 months is 853.95K, indicating liquidity. These fundamental metrics provide insight into HCAT's underlying financial health and market activity.
| ATR | 0.14 |
| Enterprise Value | 495.93M |
| Avg Vol (3 Months) | 853.95K |
| Avg Vol (10 Days) | 592.57K |
Health Catalyst, Inc. (HCAT) technical indicators as of April 16, 2026: the SMA 20 is -10.74%, SMA 50 at -20.4%, and SMA 200 at -42.39%. The RSI 14 value is 35.22, suggesting its current momentum. These technical analysis signals help assess HCAT's price trends and potential future movements.
| SMA 20 | -10.74% |
| SMA 50 | -20.4% |
| SMA 200 | -42.39% |
| RSI 14 | 35.22 |
Health Catalyst, Inc. (HCAT) stock performance overview as of April 16, 2026: The 52-week high is $5.06 (currently -65.62% below), and the 52-week low is $0.955 (currently 4.79% above). Over the past year, HCAT's performance is -59.82%, compared to the S&P 500's 25.19% change.
| 52-Week High | 5.06 |
| 52-Week High Chg | -65.62% |
| 52-Week Low | 0.9551 |
| 52-Week Low Chg | +4.79% |
| S&P 500 52-Week Chg | 25.19% |
According to market data, Health Catalyst, Inc. (HCAT) stock's recent performance metrics show that over the last month, HCAT is -7.53%, with a Year-to-Date (YTD) performance of -7.53%. Over the past year, the stock has seen a -59.82% change. These figures summarize HCAT's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 1.16 | 1.48 | 2.51 | 3.62 | 5.06 | 2.51 |
| Low | 0.9551 | 0.9551 | 0.9551 | 0.9551 | 0.9551 | 0.9551 |
| Performance | -10.16% | -7.53% | -27.54% | -42.89% | -59.82% | -7.53% |
According to current financial data, HCAT stock's P/E (TTM) ratio is -0.43, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for HCAT, including P/S (0.26), P/B (0.31), and P/FCF (-16.67), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | HCAT | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.43 | -1.22 | 14.24 | 32.59 |
| P/S (TTM) | 0.26 | 3.69 | 8.19 | 5.98 |
| P/B (TTM) | 0.31 | 0.23 | 2.69 | 4.95 |
| P/FCF (TTM) | -16.67 | 88.8 | 8.33 | 34.42 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep